Regulatory Affairs Workload at Drug Development Firms Has Increased Dramatically, According to Tufts Center for the Study of Drug Development

Medical Business News Articles, and Marketing

Regulatory Affairs Workload at Drug Development Firms Has Increased Dramatically, According to Tufts Center for the Study of Drug Development

11 March 2010 64 views No Comment

BOSTON, MA–(Marketwire – March 11, 2010) – A growing volume of global drug development and commercialization activity during the past decade has dramatically increased the workload for regulatory affairs professionals at pharmaceutical and biotech companies, according to a study recently completed by the Tufts Center for the Study of Drug Development.